CAPTRUST Financial Advisors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-4,190
Closed -$60K – 4470
2022
Q2
$60K Sell
4,190
-475
-10% -$8.24K ﹤0.01% 2606
2022
Q1
$105K Buy
4,665
+2,161
+86% +$41.9K ﹤0.01% 2234
2021
Q4
$47K Sell
2,504
-7,858
-76% -$210K ﹤0.01% 2729
2021
Q3
$340K Buy
10,362
+2,606
+34% +$97.2K ﹤0.01% 1232
2021
Q2
$331K Buy
7,756
+46
+0.6% +$1.8K ﹤0.01% 1209
2021
Q1
$296K Buy
7,710
+46
+0.6% +$1.96K ﹤0.01% 1236
2020
Q4
$335K Sell
7,664
-5,934
-44% -$223K ﹤0.01% 974
2020
Q3
$513K Buy
+13,598
New +$439K 0.01% 703

Other funds holding CSII

CAPTRUST Financial Advisors's CSII Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2022, closing a stake of 4,190 shares — an estimated $60K sold.

CAPTRUST Financial Advisors first reported a position in CSII in Q3 2020 and held it in 8 quarters. The position peaked at $513K in Q3 2020. 163 funds tracked by Wall St. Rank hold CSII as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Cardiovascular Systems, Inc. position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 4,190 Cardiovascular Systems, Inc. shares in Q3 2022, an estimated $60K.
  • CAPTRUST Financial Advisors first reported a position in Cardiovascular Systems, Inc. in Q3 2020 and held it in 8 quarters.
  • CAPTRUST Financial Advisors's Cardiovascular Systems, Inc. position peaked at $513K in Q3 2020.
  • 163 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.